Epilepsy Treatment Market Industry Analysis and Forecast (2021-2027) by Product Type, Condition & End user and Region.

Epilepsy Treatment Market size was valued at US$ 3492 Mn. in 2020 and the total revenue is expected to grow at CAGR 7.3% through 2021 to 2027, reaching nearly US$ 4175.7 Mn.

Epilepsy Treatment Market Overview:

An increase in the number of accidents, brain injuries, and a higher rate of post traumatic seizures occur in patients with brain injuries. Epilepsy is a chronic and non-communicable central nervous system disorder leading to abnormal activities, seizures, episodes of involuntary moments and sensations. It can be caused due to prenatal and perinatal cause’s congenital abnormalities or genetic conditions, severe head injury, a brain tumor, and others. Epilepsy is treated through medicines, surgeries, and other therapies. Epilepsy Treatment MarketTo know about the Research Methodology :- Request Free Sample Report 2020 is considered as a base year to forecast the market from 2021 to 2027. 2020’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years trends are considered while forecasting the market through 2027. 2020 is a year of exception and analyzed specially with the impact of lockdown by region.

Epilepsy Treatment Market Dynamics:

Increasing the number of accidents and injuries and a higher rate of post-traumatic occurrence inpatient with brain injuries and the highest rate of post traumatic seizure occurrence in patients are the main driving factors. Government funding has been rising for the development of new and effective drugs for the treatment of seizures is a high-impact rendering driver for the epilepsy drugs market growth. Post-traumatic epilepsy and post-traumatic seizure can fuel the demand for epilepsy treatment by brain damage and high sensitivity risk of elderly epilepsy. According to (WHO) World Health Organization 50 Mn. people are suffering from epilepsy in the majority of survivors are fuelling the market. The increasing geriatric population is also the second-largest factor for the increasing market growth. The growing adoption of rational polytherapy and advanced imaging technology for early diagnosis also contribute to the market growth. Emerging trend such as a business focus on innovative treatment for refractory epilepsy and doctors requiring higher effectiveness medications is increasing the R&D investments towards the epilepsy market. Time-consuming prescription approval and rising medication costs are expected to hamper the expansion of the market. Low awareness about the challenges of epilepsy can also hinder market growth.

Epilepsy Treatment Market Segment Analysis:

The Epilepsy Treatment Market is segmentation based on by Product Type, By Condition & End user Based on the Product type, The Epilepsy Treatment Market is segmented into the First Generation Anti-epileptic drug, Second Generation Anti-epileptic drug, Third Generation Anti-epileptic drug. The second Generation Anti-epileptic drug segment held the largest market share of 45% in the year 2020. Owing to the high proscription rate, tolerability, and high efficacy thanks to its novel mechanism of action of this drug. Third Generation Anti-epileptic drug is expected to witness the fastest growth with a CAGR of over 4% during the forecast period. The major factor responsible for this growth of this segment is the launch of high new efficacy drugs with the improved mechanism of action of this drug. Epilepsy Treatment Market by Product Type Based on the Condition, The Epilepsy Treatment Market is segmented into Epilepsy Drug-resistant, Intractable Drug Epilepsy, Other. The Epilepsy Drug-resistant segment is expected to hit a value of USD 2.93 Bn. during the forecast period. The advent of rational polytherapy for treating disease with minimal side effects is expected to produce the high revenue of the epilepsy market. Epilepsy Treatment Market by Condition Based on the End User, The Epilepsy Treatment Market is segmented into Hospitals, clinics, Diagnostic Centers, Other. The hospital segment held the largest market share of xx% in the year 2020. This segment is expected to remain dominant even during the forecasting period. Because of rising in the healthcare infrastructure and development in the drug development technology. This factors are attributed to the growth of the Epilepsy Treatment Market.

Epilepsy Treatment Market Regional Insights:

North America dominated the Epilepsy Treatment Market with the largest market share of 53 % in 2020. It is also expected to register a CAGR of 4.1% during the forecast period. Increase in prevalence of neurological disease and increasing geriatric population, because this disease mostly occurs in the old age people. Presence of well-established healthcare infrastructure and favorable government initiatives for the healthcare system. The presence of high drug development technology and skilled professionals has been increased the Epilepsy treatment market in this region. Asia Pacific is expected to grow the market with a CAGR of 4.5% during the forecast period. As rising disposable income level and the favorable healthcare government initiative in emerging economies such as India, China, and Japan. Rising government funding and support to improve drug development and innovative technology in it are also increasing the market revenue in this region. As the increasing need to improve the efficacy of drugs and need to develop new and enhanced antiepileptic drugs to minimize the side effect such as fatigue, dizziness, and weight gain, depression is the propelling factors expected to drive the market growth of the Epilepsy Treatment Market A new less invasive epilepsy laser surgery, dubbed LITT or laser interstitial thermal therapy was proposed by the university of Alabama at Birmingham (UAB). For certain forms of epilepsy, it is a new technique to use a laser to destroy brain tissue that is causing seizures. The objective of the report is to present a comprehensive analysis of the Epilepsy Treatment Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also helps in understanding the Epilepsy Treatment Market dynamic, structure by analyzing the market segments and project the Epilepsy Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Epilepsy Treatment Market make the report investor’s guide.

Epilepsy Treatment Market Scope: Inquire before buying

Epilepsy Treatment Market by Scope

Epilepsy Treatment Market, by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Epilepsy Treatment Market Key Players

• LivaNova PLC • GlaxoSmithKline PLC • Eisai Co. Ltd. • Pfizer Inc. • Medtronic PLC • UCB SA • NeuroPace Inc. • GW Pharmaceuticals PLC • Novartis AG • Johnson & Johnson Services Inc. • Abbott Laboratories • DiaGenic ASA • Quanterix • Merck KGaA

Frequently Asked Questions:

1] Which segments are covered in Epilepsy Treatment Market report? Ans. The segments covered in Epilepsy Treatment Market report are based on by Product Type, By Condition & End user 2] Which region is expected to hold the highest share in the Epilepsy Treatment Market? Ans. North America is expected to hold the highest share in the Epilepsy Treatment Market 3] What is the market size of Epilepsy Treatment Market by 2027? Ans. The market size of Epilepsy Treatment Market by 2027 is US $ 4175.7Mn. 4] Who are the top key players in the Epilepsy Treatment Market? Ans. LivaNova PLC, GlaxoSmithKline PLC , Eisai Co. Ltd. , Pfizer Inc. , Medtronic PLC UCB SA, NeuroPace Inc., GW Pharmaceuticals PLC, Novartis AG (Switzerland), Johnson & Johnson Services Inc., Abbott Laboratories. 5] What was the market size of Epilepsy Treatment Market in 2020? Ans. The market size of Epilepsy Treatment Market in 2020 was US $ 3492 Mn.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Epilepsy Treatment Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Epilepsy Treatment Market 3.4. Geographical Snapshot of the Epilepsy Treatment Market , By Manufacturer share 4. Epilepsy Treatment Market Overview, 2020-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Epilepsy Treatment Market 5. Supply Side and Demand Side Indicators 6. Epilepsy Treatment Market Analysis and Forecast, 2020-2027 6.1. Epilepsy Treatment Market Size & Y-o-Y Growth Analysis. 7. Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 7.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 7.1.1. First Generation Anti-epileptic drug 7.1.2. Second Generation Anti-epileptic drug 7.1.3. Third Generation Anti-epileptic drug 7.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 7.2.1. Epilepsy Drug resistant 7.2.2. Intractable Drug Epilepsy 7.2.3. Other 7.2.4. Market Size (Value) Estimates & Forecast By End User, 2020-2027 7.2.5. Hospital 7.2.6. Clinics 7.2.7. Other 8. Epilepsy Treatment Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2020-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 9.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 9.1.1. First Generation Anti-epileptic drug 9.1.2. Second Generation Anti-epileptic drug 9.1.3. Third Generation Anti-epileptic drug 9.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 9.2.1. Epilepsy Drug resistant 9.2.2. Intractable Drug Epilepsy 9.2.3. Other 9.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 9.3.1. Hospital 9.3.2. Clinics 9.3.3. Other 10. North America Epilepsy Treatment Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 11.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 11.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 11.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 12. Canada Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 12.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 12.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 12.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 13. Mexico Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 13.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 13.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 13.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 14. Europe Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 14.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 14.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 14.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 15. Europe Epilepsy Treatment Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 16.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 16.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 16.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 17. France Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 17.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 17.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 17.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 18. Germany Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 18.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 18.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 18.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 19. Italy Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 19.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 19.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 19.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 20. Spain Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 20.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 20.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 20.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 21. Sweden Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 21.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 21.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 21.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 22. CIS Countries Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 22.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 22.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 22.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 23. Rest of Europe Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 23.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 23.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 23.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 24. Asia Pacific Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 24.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 24.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 24.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 25. Asia Pacific Epilepsy Treatment Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates &Forecast By Country, 2020-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 26.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 26.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 26.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 27. India Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 27.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 27.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 27.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 28. Japan Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 28.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 28.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 28.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 29. South Korea Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 29.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 29.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 29.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 30. Australia Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 30.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 30.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 30.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 31. ASEAN Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 31.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 31.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 31.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 32. Analysis and Forecasts, 2020-2027 32.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 32.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 32.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 33. Middle East Africa Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 33.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 33.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 33.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 34. Middle East Africa Epilepsy Treatment Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 35.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 35.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 35.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 36. GCC Countries Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 36.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 36.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 36.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 37. Egypt Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 37.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 37.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 37.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 38. Nigeria Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 38.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 38.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 38.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 39. Rest of ME&A Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 39.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 39.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 39.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 40. South America Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 40.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 40.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 40.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 41. South America Epilepsy Treatment Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 42.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 42.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 42.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 43. Argentina Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 43.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 43.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 43.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 44. Rest of South America Epilepsy Treatment Market Analysis and Forecasts, 2020-2027 44.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 44.2. Market Size (Value) Estimates & Forecast By Condition Type, 2020-2027 44.3. Market Size (Value) Estimates & Forecast By End User, 2020-2027 44.4. Geographic Footprint of Major Players in the Epilepsy Treatment Market 44.5. Competition Matrix 44.5.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 44.5.2. New Product Launches and Product Enhancements 44.5.3. Market Consolidation 44.5.3.1. M&A by Regions, Investment and Verticals 44.5.3.2. M&A, Forward Integration and Backward Integration 44.5.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45. Company Profile : Key Players 45.1.1. LivaNova PLC 45.1.1.1. Company Overview 45.1.1.2. Financial Overview 45.1.1.3. Geographic Footprint 45.1.1.4. Product Portfolio 45.1.1.5. Business Strategy 45.1.1.6. Recent Developments 45.1.2. LivaNova PLC 45.1.3. GlaxoSmithKline PLC 45.1.4. Eisai Co. Ltd. 45.1.5. Pfizer Inc. 45.1.6. Medtronic PLC 45.1.7. UCB SA 45.1.8. NeuroPace Inc. 45.1.9. GW Pharmaceuticals PLC 45.1.10. Novartis AG (Switzerland) 45.1.11. Johnson & Johnson Services Inc. 45.1.12. Abbott Laboratories 46. Primary Key Insights

About This Report

Report ID 124423
Category Healthcare
Published Date Oct 2021
Updated Date
Contact Us